Showing results (171-180 of 854) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|January 9, 2014
Impact of the Affordable Care Act on stem cell transplantationStephanie Farnia, Alicia Gedan, Michael BooCurrent Hematologic Malignancy Reports|January 9, 2014
Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT)Ehab Atallah, Kathryn Bylow, Jesse Troy, et al.Current Hematologic Malignancy Reports|May 4, 2021
Laboratory Evaluation and Pathological Workup of Neoplastic Monocytosis - Chronic Myelomonocytic Leukemia and BeyondSiba El Hussein, Joseph D Khoury, L Jeffrey Medeiros, et al.Current Hematologic Malignancy Reports|May 3, 2021
IDH Inhibitors in AML-Promise and PitfallsHannah McMurry, Luke Fletcher, Elie TraerCurrent Hematologic Malignancy Reports|February 10, 2023
CAR-T Cell Therapy: the Efficacy and Toxicity BalanceKaran L Chohan, Elizabeth L Siegler, Saad S KenderianCurrent Hematologic Malignancy Reports|December 28, 2025
Impact of Germline DNA Repair Mutations on Clonal Hematopoiesis and Myeloid Neoplasm DevelopmentKateryna Fedorov, Leo Y Luo, Alexander G Bick, et al.Current Hematologic Malignancy Reports|November 4, 2025
From MRD To Match: the Role of Allogeneic Hematopoietic Cell Transplant in Philadelphia-Negative B-ALLJessica El-Asmar, John C Molina, Betty Ky HamiltonCurrent Hematologic Malignancy Reports|November 5, 2025
Plasmacytoid Dendritic Cell-Expansion in Acute Myeloid Leukemia (pDC‑AML): a Review of Clinicopathologic Features, Genetics, and OutcomesAzza E A Abdalla, Mohammed Abdulgayoom, Abdulrahman F Al-Mashdali, et al.Current Hematologic Malignancy Reports|October 15, 2025
Use of Patient-Reported Outcome Measures in Clinical Studies of Chronic Myeloid Leukemia: A Scoping Literature ReviewKathryn E Flynn, Lovneet Saini, Aditi Kataria, et al.Current Hematologic Malignancy Reports|September 26, 2025
Chronic Myelomonocytic Leukemia Microenvironment in Disease Progression and Therapy: Focus on Stepwise Reconfiguring of Myeloid-Immune Cell Interactions Driving Immune ToleranceAli Khalid A Alsugair, Abhishek MangaonkarPageof 86